Analysis of the activity and safety of weekly low‐dose bevacizumab‐based regimens in heavily pretreated patients with metastatic breast cancer

BACKGROUND: Currently, there are no standard regimens for metastatic breast cancer patients (MBC) who have failed ≥ 3 chemotherapy treatments. The aim of this study was to assess whether weekly low‐dose bevacizumab‐based regimens were well tolerated and would improve efficacy in MBC patients who had...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Xiaoyu, Hong, Ruoxi, Fan, Ying, Yuan, Peng, Wang, Jiayu, Sang, Die, Chen, Junlin, Zhao, Chunying, Ou, Kaiping, Ma, Fei, Xu, Binghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928366/
https://www.ncbi.nlm.nih.gov/pubmed/29575760
http://dx.doi.org/10.1111/1759-7714.12627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928366/
https://www.ncbi.nlm.nih.gov/pubmed/29575760
http://dx.doi.org/10.1111/1759-7714.12627

Ejemplares similares